Document is current
Any future updates will be listed below
-
Authors
Sharma, Niti
Kim, Danyeong
Sharma, Himadri
Kim, Moon Il
Lee, Hyon
Kim, Minju
Ryoo, Nayoung
Kang, Min Ju
Pyun, Jung-Min
Park, Young Ho
Ryu, Jisun
Oh, Hyun Jung
Yang, Hyun-Sik
Kim, Hang-Rai
Kim, Geon Ha
Han, Sangwon
Yang, YoungSoon
Youn, Young Chul
Teunissen, Charlotte
Zetterberg, Henrik
Scheltens, Philip
An, Seong Soo A.
Kim, Young-Bum
Kim, SangYun
,
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (RS-2023-00251396)
Korea Institute of Marine Science and Technology promotion (RS-2025-02292973)
- License Information
-
More Information
Article History
Received: 28 April 2025
Accepted: 19 August 2025
First Online: 26 September 2025
Declarations
:
: Not applicable.
: Not applicable.
: HZ serves at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, and Roche, and was a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which was a part of the GU Ventures Incubator Program (outside submitted work). The rest of the authors have nothing to declare.
